Mobile Cardiac Telemetry Device Market Value By Disease Indication (Heart Failure, Angina Pectoris, Atherosclerosis, Others), By Application (Patch-based, Lead-based), By End User (Home Care Settings, Specialty Clinics, Hospitals, Diagnostic Centers, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Industry Analysis, Share & Forecast, 2023 - 2032

Market Overview:

Mobile Cardiac Telemetry Device Market size exceeded USD 1.0 Billion in 2022 and is expected to showcase a CAGR of over 10.8% from 2023 to 2032. By the end of the forecast period, the market is anticipated to surpass USD 2.7 Billion.

Mobile Cardiac Telemetry (MCT) is a medical monitoring system that uses a small, portable device to continuously monitor a patient's heart activity. The device is worn on the patient's body, and it records the heart's electrical activity, heart rate, and rhythm. MCT is often used to diagnose and monitor arrhythmias, which are irregular heartbeats that can be dangerous if left untreated. MCT devices typically include a small monitor, electrodes that are attached to the patient's chest, and a wireless transmitter that sends the data to a remote monitoring center. The device can be worn for several days or weeks, depending on the patient's needs.

To get more info about this report - 

This system provides a non-invasive, convenient, and accurate way to monitor a patient's heart activity in real-time, even when they are not in the hospital or clinic. This can help doctors to diagnose and treat heart conditions more effectively, and it can also provide patients with peace of mind by allowing them to monitor their own heart health.

Driver:

Increasing Prevalence of Cardiovascular Diseases: The prevalence of cardiovascular diseases such as heart attacks, strokes, and arrhythmias is increasing globally. This has led to a rising demand for advanced diagnostic and monitoring devices such as Mobile Cardiac Telemetry devices that can provide real-time monitoring of patients' heart health.

Growing Geriatric Population: The elderly population is more prone to cardiovascular diseases, and as the global population ages, the demand for Mobile Cardiac Telemetry devices is expected to increase. The geriatric population is also more likely to prefer remote monitoring options, such as Mobile Cardiac Telemetry devices, over traditional hospital stays.

Rising Preference for Remote Monitoring: Patients are increasingly seeking remote monitoring options that allow them to receive continuous care and monitoring in the comfort of their own homes. Mobile Cardiac Telemetry devices enable remote monitoring, which is becoming more popular with patients who prefer to avoid hospital stays or frequent visits to healthcare facilities.

By End User Synopsys:

In terms of end-user, hospitals sector held the largest share of the global mobile cardiac telemetry device market in 2022. Increase in the prevalence of cardiovascular diseases is one of the main drivers of the market. Cardiovascular diseases are the leading cause of death worldwide, according to the World Health Organization (WHO). As a result, demand for cardiac monitoring devices has increased, propelling the hospitals segment. 

Moreover, the hospital segment is benefiting from an increase in the number of strategic collaborations between hospitals and device manufacturers. Philips and the University of Michigan Health System, for example, announced a strategic collaboration in April 2021 to develop and deploy advanced cardiac monitoring solutions.

Regional Overview:

North America is currently the largest market for MCT devices, accounting for the majority of the global revenue share. This is attributed to the presence of leading manufacturers, a well-established healthcare infrastructure, and high healthcare expenditure. The U.S. held the highest market in this region, followed by Canada.

Europe is the second-largest market for mobile cardiac telemetry device. This growth is driven by the increasing incidence of cardiovascular diseases, the availability of advanced healthcare infrastructure, and a large geriatric population. The Germany, U.K., and France are the major markets in this region. 

However, the Asia-Pacific region is slated to experience the highest growth rate in the mobile cardiac telemetry device market. This growth is credited to the increasing adoption of advanced medical technologies, a large patient pool, and rising healthcare expenditure in countries such as China, India, and Japan. The region is also witnessing a shift towards value-based healthcare, which is expected to drive the adoption of MCT devices.

Recent Development:

• In May 2021, VitalConnect introduced the VitalPatch RTM mobile cardiac telemetry solution. The solution has a versatile and programmable platform that can meet a variety of cardiac monitoring requirements.
   
• In July 2021, Medtronic plc has received approval from FDA for 2 AccuRhythm AI algorithms for use with the LINQ II insertable cardiac monitor. This system is used for the diagnosis and treatment of irregular heart rhythms.

Top companies includes in the global mobile cardiac telemetry device market are:

• ScottCare
• Biotricity, Inc.
• VitalConnect
• Medtronic plc
• Welch Allyn
• BioTelemetry, Inc.
• Applied Cardiac Systems, Inc.
• Medicomp, Inc.
• Zoll Medical Corporation
• Preventice Solutions
• Telerhythmics LLC
• iRhythm Technologies, Inc.
• Other Players

To get more info about this report - 

In-depth analysis of mobile cardiac telemetry device market along with industry coverage and forecasting for the following segments:

Market Value, By Disease Indication

• Heart Failure
• Angina Pectoris
• Atherosclerosis
• Others

Market Value, By Application

• Patch-based
• Lead-based

Market Value, By End User

• Home Care Settings
• Specialty Clinics
• Hospitals
• Diagnostic Centers
• Others

Market Value, By Region

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America